Table 4.
Instrument b | Number of days of work missed over the previous month, mean | Number of days with productivity ≤50% at work over the previous month, mean | Rate of arthritis interference with work productivity over previous month, mean c | |||
---|---|---|---|---|---|---|
Worse | Better | Worse | Better | Worse | Better | |
BASDAI | ||||||
axSpA (cutoff 5.20 and 7.50) | 3.27d | 0.70 | 7.95d | 2.86 | 5.44d | 3.45 |
n = 59 | n = 57 | n = 59 | n = 57 | n = 59 | n = 57 | |
AS (cutoff 5.20 and 7.30) | 3.12d | 0.56 | 8.12d | 2.79 | 5.32e | 3.71 |
n = 34 | n = 34 | n = 34 | n = 34 | n = 34 | n = 34 | |
nr-axSpA (cutoff 5.40 and 7.60) | 3.19f | 0.79 | 9.63f | 3.85 | 5.74d | 3.26 |
n = 27 | n = 28 | n = 27 | n = 28 | n = 27 | n = 28 | |
BASFI | ||||||
axSpA (cutoff 3.80 and 6.55) | 4.02d | 0.68 | 7.34f | 4.22 | 5.79d | 3.55 |
n = 56 | n = 56 | n = 56 | n = 56 | n = 56 | n = 56 | |
AS (cutoff 4.30 and 6.80) | 3.09e | 0.87 | 5.47 | 2.73 | 5.31d | 3.40 |
n = 32 | n = 30 | n = 32 | n = 30 | n = 32 | n = 30 | |
nr-axSpA (cutoff 3.20 and 6.40) | 6.04d | 0.44 | 8.81 | 5.25 | 6.52# | 3.63 |
n = 27 | n = 25 | n = 27 | n = 25 | n = 27 | n = 25 | |
Total Spine Pain | ||||||
axSpA (cutoff 6 and 8) | 2.97e | 1.10 | 7.01d | 2.99 | 5.57d | 3.75 |
n = 88 | n = 82 | n = 88 | n = 82 | n = 88 | n = 82 | |
AS (cutoff 6 and 8) | 2.87d | 0.52 | 6.40e | 2.50 | 5.17e | 3.90 |
n = 47 | n = 42 | n = 47 | n = 42 | n = 47 | n = 42 | |
nr-axSpA (cutoff 6 and 8) | 3.07 | 1.70 | 7.71e | 3.51 | 6.02d | 3.59 |
n = 41 | n = 40 | n = 41 | n = 40 | n = 41 | n = 40 | |
SF-36 PCS | ||||||
axSpA (cutoff 37.54 and 27.49) | 2.85e | 0.76 | 6.13f* | 2.98 | 5.85d | 3.28 |
n = 54 | n = 55 | n = 54 | n = 55 | n = 54 | n = 55 | |
AS (cutoff 37.44 and 27.93) | 2.72e | 0.62 | 6.48 | 2.86 | 5.62d | 3.41 |
n = 29 | n = 29 | n = 29 | n = 29 | n = 29 | n = 29 | |
nr-axSpA (cutoff 37.76 and 26.58) | 3.84f | 0.92 | 6.52 | 3.12 | 6.64d | 3.12 |
n = 25 | n = 26 | n = 25 | n = 26 | n = 25 | n = 26 | |
SF-36 MCS | ||||||
axSpA (cutoff 49.84 and 32.24) | 4.78d | 0.81 | 8.18e | 3.54 | 5.58e | 3.93 |
n = 55 | n = 80 | n = 55 | n = 80 | n = 55 | n = 80 | |
AS (cutoff 52.73 and 32.87) | 3.86e | 0.89 | 7.00f | 3.00 | 5.07 | 4.18 |
n = 29 | n = 28 | n = 29 | n = 28 | n = 29 | n = 28 | |
nr-axSpA (cutoff 46.98 and 30.79) | 5.65d | 0.69 | 8.58e | 3.23 | 6.08e | 3.50 |
n = 26 | n = 26 | n = 26 | n = 26 | n = 26 | n = 26 | |
ASQoL | ||||||
axSpA (cutoff 8.50 and 15.00) | 4.40d | 0.62 | 8.00d | 3.35 | 6.26d | 2.98 |
n = 58 | n = 90 | n = 58 | n = 90 | n = 58 | n = 90 | |
AS (cutoff 8.00 and 14.91) | 3.77d | 0.42 | 7.53 | 3.61 | 5.73d | 3.03 |
n = 30 | n = 31 | n = 30 | n = 31 | n = 30 | n = 31 | |
nr-axSpA (cutoff 9.00 and 15.00) | 5.07d | 0.77 | 8.50e | 3.33 | 6.82d | 3.00 |
n = 28 | n = 30 | n = 28 | n = 30 | n = 28 | n = 30 |
aASQoL: Ankylosing spondylitis quality of life; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; MCS: Mental Components Summary; PCS: Physical Components Summary; SF-36: Short form 36 items. bCutoff points represent the first and third quartiles of baseline scores: “Worse” state is defined for each individual measure as BASDAI score at or above the third quartile; BASFI score at or above the third quartile; Total Spine Pain score at or above the third quartile; ASQoL at or above the third quartile; SF-36 MCS at or below the first quartile; SF-36 PCS at or below the first quartile; “Better” state defined for each individual measure as BASDAI score at or below the first quartile; BASFI score at or below the first quartile; Total Spine Pain score at or below the first quartile; ASQoL score at or below the first quartile; SF-36 MCS, PCS at or above the third quartile; cWPS Q4 is scored on a 0 to 10 scale, where 0 = no interference and 10 = complete interference. d P ≤ 0.001; e P ≤ 0.01; f P ≤ 0.05; nonparametric bootstrap-t method with a variance stabilizing transformation, 10,000 replications.